NLS Pharma (Equity Financing)
Funding Details
Awarder
Inbox
Date Award
May 17, 2025
Vertical
Biopharmaceuticals
Funding URL
View Funding Page
Funding Amount
$3,000,000
Company Info
Traction
The company intends to use the net proceeds from the offering for working capital, general corporate purposes, and expenses relating to the merger with Kadimastem Ltd.
Market
Central Nervous System Disorders
Location
Switzerland
Company Description

NLS Pharma is a clinical-stage drug development company focusing on neurobehavioral and neurocognitive disorders and their pharmacognosia.

Links
WebsiteCrunchbaseLinkedInTwitter
Back to HomeBack to Biopharmaceuticals DealsView Funding Announcement